Impacts of COVID-19 on Liver Cancers: During and after the Pandemic

von Chan, Stephen Lam, Kudo, Masatoshi
Veröffentlicht in Liver Cancer (2020)

Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery

von Choy, Chi Tung, Wong, Chi Hang, Chan, Stephen Lam
Veröffentlicht in Front Genet (2019)

Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment

von Siu, Elaine Hon-Lam, Chan, Anthony Wing-Hung, Chong, Charing Ching-Ning, Chan, Stephen Lam, Lo, Kwok-Wai, Cheung, Siu Tim
Veröffentlicht in Transl Gastroenterol Hepatol (2018)

Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma

von Zhou, Qian, Wong, Chi Hang, Lau, Cecilia Pik Yuk, Hui, Connie Wun Chun, Lui, Vivian Wai Yan, Chan, Stephen Lam, Yeo, Winnie
Veröffentlicht 2013

Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade

von Kwong, Tsz Tung, Wong, Chi Hang, Zhou, Jing Ying, Cheng, Alfred Sze Lok, Sung, Joseph Jao Yiu, Chan, Anthony Wing Hung, Chan, Stephen Lam
Veröffentlicht in JHEP Rep (2020)

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

von Kudo, Masatoshi, Han, Kwang-Hyub, Ye, Sheng-Long, Zhou, Jian, Huang, Yi-Hsiang, Lin, Shi-Ming, Wang, Chung-Kwe, Ikeda, Masafumi, Chan, Stephen Lam, Choo, Su Pin, Miyayama, Shiro, Cheng, Ann Lii
Veröffentlicht in Liver Cancer (2020)

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Mult...

von Yoo, Changhoon, Kim, Jwa Hoon, Ryu, Min-Hee, Park, Sook Ryun, Lee, Danbi, Kim, Kang Mo, Shim, Ju Hyun, Lim, Young-Suk, Lee, Han Chu, Lee, Joycelyn, Tai, David, Chan, Stephen Lam, Ryoo, Baek-Yeol
Veröffentlicht in Liver Cancer (2021)

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study

von Chan, Stephen Lam, Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Yuen, Becky Wing‐Yan, Luk, Hester Wing‐Sum, Lui, Rashid Nok‐Shun, Chan, Henry Lik‐Yuen, Mok, Tony Shu‐Kam, Wong, Grace Lai‐Hung
Veröffentlicht in Cancer Med (2020)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

von Hui, Vicki Wing-Ki, Chan, Stephen Lam, Wong, Vincent Wai-Sun, Liang, Lilian Yan, Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Yuen, Becky Wing-Yan, Luk, Hester Wing-Sum, Tse, Yee-Kit, Lee, Hye-Won, Chan, Henry Lik-Yuen, Wong, Grace Lai-Hung
Veröffentlicht in JHEP Rep (2020)

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

von Qin, Shukui, Chan, Stephen Lam, Sukeepaisarnjaroen, Wattana, Han, Guohong, Choo, Su Pin, Sriuranpong, Virote, Pan, Hongming, Yau, Thomas, Guo, Yabing, Chen, Minshan, Ren, Zhenggang, Xu, Jianming, Yen, Chia-Jui, Lin, Zhong-Zhe, Manenti, Luigi, Gu, Yi, Sun, Yongjian, Tiedt, Ralph, Hao, Lu, Song, Wenjie, Tanwandee, Tawesak
Veröffentlicht in Ther Adv Med Oncol (2019)

Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma

von Chan, Stephen Lam, Wong, Lin-Lee, Chan, Kwan-Chee Allen, Chow, Chit, Tong, Joanna Hung-Man, Yip, Terry Cheuk-Fung, Wong, Grace Lai-Hung, Chong, Charing Ching-Ning, Liu, Po-Hong, Chu, Cheuk-Man, Wong, Vincent Wai-Sun, To, Ka-Fai, Reeves, Helen L., Chan, Anthony Wing-Hung
Veröffentlicht in Liver Cancer (2020)

Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma

von Poon, Ronnie Tung-Ping, Cheung, Tom Tan-To, Kwok, Philip Chong-Hei, Lee, Ann-Shing, Li, Tat-Wing, Loke, Kwok-Loon, Chan, Stephen Lam, Cheung, Moon-Tong, Lai, Tak-Wing, Cheung, Chin-Cheung, Cheung, Foon-Yiu, Loo, Ching-Kong, But, Yiu-Kuen, Hsu, Shing-Jih, Yu, Simon Chun-Ho, Yau, Thomas
Veröffentlicht in Liver Cancer (2015)

Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis

von Zeng, Xuezhen, Zhou, Jingying, Xiong, Zhewen, Sun, Hanyong, Yang, Weiqin, Mok, Myth T. S., Wang, Jing, Li, Jingqing, Liu, Man, Tang, Wenshu, Feng, Yu, Wang, Hector Kwong-Sang, Tsang, Shun-Wa, Chow, King-Lau, Yeung, Philip Chun, Wong, John, Lai, Paul Bo-San, Chan, Anthony Wing-Hung, To, Ka Fai, Chan, Stephen Lam, Xia, Qiang, Xue, Jing, Chen, Xiao, Yu, Jun, Peng, Sui, Sung, Joseph Jao-Yiu, Kuang, Ming, Cheng, Alfred Sze-Lok
Veröffentlicht in Cell Mol Immunol (2020)